Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter. by Tasara, T et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2008
Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from
cattle and sheep at slaughter. 
Tasara, T; Bielaszewska, M; Nitzsche, S; Karch, H; Zweifel, C; Stephan, R
Tasara, T; Bielaszewska, M; Nitzsche, S; Karch, H; Zweifel, C; Stephan, R (2008). Activatable Shiga toxin 2d
(Stx2d) in STEC strains isolated from cattle and sheep at slaughter. Veterinary Microbiology, 131(1-2):199-204.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Veterinary Microbiology 2008, 131(1-2):199-204.
Tasara, T; Bielaszewska, M; Nitzsche, S; Karch, H; Zweifel, C; Stephan, R (2008). Activatable Shiga toxin 2d
(Stx2d) in STEC strains isolated from cattle and sheep at slaughter. Veterinary Microbiology, 131(1-2):199-204.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Veterinary Microbiology 2008, 131(1-2):199-204.
Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from
cattle and sheep at slaughter. 
Abstract
Shiga toxin producing Escherichia coli (STEC) harbouring the stx2d-activatable gene and expressing the
mucus- and elastase-activatable phenotype have been associated with severe outcomes of human
disease. However, there is limited data available on the occurrence of such strains in livestock
reservoirs. In this study, we analyzed 11 STEC strains isolated from healthy cattle and sheep at slaughter
that were originally detected to contain the stx2c allele, for the presence of the stx2d-activatable
genotype. Ten of the 11 strains displayed the stx2d-activatable genotype as determine by PstI restriction
fragment length polymorphism (RFLP) of 890-bp fragments of their stx genes. However, only in six of
10 strains whose stx genes were sequenced, the presence of stx2d-activatable could be confirmed based
on the predicted amino acid sequence of their StxA subunits; the remaining four strains contained Stx2c
A subunit. Five of the six strains which contained stx2d-activatable displayed the activatable phenotype
on Vero cells. Genes for adhesins such as the outer membrane protein intimin (eae), which is essential
for the intimate attachment and the formation of attaching-and-effacing lesions on intestinal epithelial
cells, or the STEC autoagglutinating adhesin (saa), potentially important in eae-negative STEC, were
not detected. Moreover, all the strains tested negative for EHEC-hlyA encoding enterohaemorrhagic E.
coli (EHEC) hemolysin. To our knowledge, this is the first study that reports the presence of STEC
harbouring stx2d-activatable and producing the activatable Stx2d in fecal samples of sheep. Therefore
both cattle and sheep are reservoirs of such strains and potential sources of human infections. This is of
particular importance, because in contrast to other eae-negative STEC, strains producing
Stx2dactivatable may cause severe diseases such as bloody diarrhoea and haemolytic uremic syndrome
in humans. 
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Abstract 28 
Shiga toxin producing Escherichia coli (STEC) harbouring the stx2d-activatable gene and 29 
expressing the mucus- and elastase-activatable phenotype have been associated with severe 30 
outcomes of human disease. However, there is limited data available on the occurrence of 31 
such strains in livestock reservoirs. In this study, we analyzed 11 STEC strains isolated from 32 
healthy cattle and sheep at slaughter that were originally detected to contain the stx2c allele, 33 
for the presence of the stx2d-activatable genotype. Ten of the 11 strains displayed the stx2d-activatable 34 
genotype as determine by PstI restriction fragment length polymorphism (RFLP) of 890-bp 35 
fragments of their stx genes. However, only in six of 10 strains whose stx genes were 36 
sequenced, the presence of stx2d-activatable could be confirmed based on the predicted amino acid 37 
sequence of their StxA subunits; the remaining four strains contained Stx2c A subunit. Five of 38 
the six strains which contained stx2d-activatable displayed the activatable phenotype on Vero 39 
cells. Genes for adhesins such as the outer membrane protein intimin (eae), which is essential 40 
for the intimate attachment and the formation of attaching-and-effacing lesions on intestinal 41 
epithelial cells, or the STEC autoagglutinating adhesin (saa), potentially important in eae-42 
negative STEC, were not detected. Moreover, all the strains tested negative for EHEC-hlyA 43 
encoding enterohaemorrhagic E. coli (EHEC) hemolysin. 44 
To our knowledge, this is the first study that reports the presence of STEC harbouring 45 
stx2d-activatable and producing the activatable Stx2d in fecal samples of sheep. Therefore both 46 
cattle and sheep are reservoirs of such strains and potential sources of human infections. This 47 
is of particular importance, because in contrast to other eae-negative STEC, strains producing 48 
Stx2dactivatable may cause severe diseases such as bloody diarrhoea and haemolytic uremic 49 
syndrome in humans. 50 
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1. Introduction 53 
Shiga toxin-producing E. coli (STEC) are responsible for a number of human diseases, 54 
including watery or bloody diarrhoea, haemorrhagic colitis (HC) and the life-threatening 55 
haemolytic-uraemic syndrome (HUS). Pathogenicity of STEC is associated with various 56 
virulence factors, the most important of which are exotoxins Shiga toxins (Stxs). These toxins 57 
can be subdivided into two main groups, Stx1 and Stx2 (Karmali, 1989; Paton and Paton, 58 
1998). Nucleotide sequence analyses of the stx1 and stx2 genes revealed the existence of 59 
different variants in both groups. So far, three stx1 subtypes (stx1, stx1c, stx1d) and several stx2 60 
variants (e.g. stx2c, stx2d, stx2e, stx2f, stx2g) have been described (Schmitt et al., 1991; Melton-61 
Celsa et al., 1996; Pierard et al., 1998; Schmidt et al., 2000; Leung et al., 2003; Kuczius et al., 62 
2004; Sonntag et al., 2005a; Sonntag et al., 2005b). All Stxs studied until now are composed 63 
of an enzymatically active A subunit and a B subunit pentamer responsible for the binding of 64 
the Stx holotoxin to the specific receptor on the target host cells. 65 
A particular feature of the Stx2 variant designated Stx2dactivatable (Melton Celsa et al., 1996) is 66 
that its cytotoxicity to Vero cells is increased (activated) 10-1000-fold when the toxin is pre-67 
incubated with mucus obtained from the small intestine of mice (Melton-Celsa et al., 1996; 68 
Kokai-Kun et al., 2000). Comparison of the activatable Stx2d and nonactivatable Stx2c 69 
reveals two differences in the predicted amino acid sequences of the A2 subunits between the 70 
two toxins (Melton-Celsa et al., 1996). The A2 subunits differ at amino acid positions 291 and 71 
297, where serine and glutamic acid, respectively, are found in Stx2dactivatable compared to 72 
phenylalanine and lysine at the same positions in Stx2c (Melton-Celsa et al., 2002).  73 
Recently, Bielaszewska et al. (2006) investigated the prevalence of Stx2dactivatable among 74 
STEC strains isolated from humans and the association between production of this Stx variant 75 
and the clinical outcome of infection. Among eae-negative STEC, which typically cause mild 76 
diarrhea or asymptomatic infections, production of Stx2dactivatable was significantly associated 77 
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with severe disease such as bloody diarrhea, and systemic complications such as HUS. There 78 
is, however, only limited data regarding the prevalence of strains harbouring the stx2d-activatable 79 
gene in livestock reservoirs (Bertin et al., 2001; Gobius et al., 2003). In two previous studies 80 
we isolated 11 strains from healthy cattle and sheep at slaughter (Zweifel et al., 2004; Zweifel 81 
et al., 2005), that were designated stx2c-positive based on the genotyping scheme of Piérard et 82 
al. (1998). However, a more recent study revealed that this method is not able to distinguish 83 
stx2c from the stx2d-activatable genotype (Jelacic et al., 2003).  84 
The aim of this study was therefore (i) to further characterize the Shiga toxin genotypes 85 
and other virulence factors in these strains and ii) to confirm the presence and expression of 86 
the stx2d-activatable allele by an in vitro cell cytotoxicity activation assay. 87 
 88 
2. Materials and methods 89 
2.1 Strains 90 
Seven cattle and four sheep strains, designated stx2c-positive based on genotyping scheme of 91 
Piérard et al. (1998) were further characterized. The strains were previously isolated from 92 
healthy animals at slaughter and belong to the serotypes O87:H16, O2:H29, O148:H8, 93 
O174:H21, ONT:H21 and ONT:H- (Zweifel et al., 2004; Zweifel et al., 2005).  94 
 95 
2.2 Determination of the stx2d-activatable genotype 96 
In order to distinguish the stx2d-activatable allele from stx2c the strains were tested by PCR using 97 
primers SLT-II-vc and CKS2 (Jelacic et al., 2003). Briefly, cellular DNA was extracted using 98 
the Qiagen DNeasy® Tissue Kit (QIAGEN, Hombrechtikon, CH) in accordance with the 99 
manufacturer’s protocol. PCR assays were performed in a T3 thermocycler (Biometra, 100 
Göttingen, Germany). Reagents were purchased from PROMEGA (Madison, Wis.) and 101 
primers synthesized by MICROSYNTH (Balgach, Switzerland). The resulting 890 bp 102 
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amplicons were analyzed by restriction enzyme digest using PstI to distinguish between the 103 
stx2d-activatable and stx2c genotypes. This enzyme cuts the stx2c amplicons into fragments of 504 104 
bp and 386 bp, but does not digest amplicons of the stx2d-activatable allele (Jelacic et al., 2003). 105 
The DNA sequences of stx A subunits in strains with non-digestable PCR products were 106 
determined. Briefly primers p1(5CAACGCGCCATATTTATTTACCAG3) and 107 
p2(5TCCAGTACTCTTTTCCGGCCA3) flanking the stx A subunit gene locus were used to 108 
amplify a 1215 bp region spanning the full length stx A subunit gene using the FastStart High 109 
Fidelity PCR system (Roche Molecular Diagnostics, Penzberg, Germany). The resulting PCR 110 
product from each strain was gel-purified using the MiniElute gel extraction (Qiagen, 111 
Switzerland) and sequenced in both directions using p1 and p2 as primers (Microsynth AG, 112 
Switzerland). 113 
Ten of the 11 strains were tested using the Vero cell assay to determine if the cytotoxicity was 114 
enhanced upon incubation with mouse intestinal mucus and elastase. The mucus isolation was 115 
performed according to Melton-Celsa et al. (1996) with slight modifications. After pre-116 
treatement with streptomycin in the drinking water (5g/liter) and food removal for 18 h, six 117 
mice were sacrificed, mucus was immediately harvested from the small and large intestines 118 
and the harvests were pooled. The activation assays were performed as described 119 
(Bielaszewska et al., 2006) using 1 mg/ml of the mucus or 1 unit of porcine pancreatic 120 
elastase (EC 3.4.21.36; Calbiochem, Darmstadt, Germany).  121 
 122 
2.3 Further strain characterization 123 
Strains were further tested by PCR for stx1 (Friedrich et al., 2002), eae encoding for intimin 124 
(Friedrich et al., 2002), EHEC-hlyA encoding for enterohemorrhagic E. coli (EHEC) 125 
hemolysin (Schmidt et al., 1995), and saa encoding for STEC autoagglutinating adhesin 126 
(Paton and Paton, 2002).  127 
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3. Results and discussion 129 
Based on restriction fragment analysis and predicted amino acid sequence of their StxA 130 
subunits, six of the eleven strains tested positive for stx2d-activatable (Table 1). Four additional 131 
strains, which were also predicted to possess stx2d-activatable  based on the PstI RFLP of 890-bp 132 
amplicons of their stx genes, could not be confirmed to harbour this allele using sequence 133 
analysis. Based on predicted amino acid sequences of their StxA subunits, these strains 134 
contained phenylalanine and lysine (typical for Stx2c A2 subunit) instead of serine and 135 
glutamic acid (typical for the A2 subunit of Stx2dactivatable) at the positions 291 and 297, 136 
respectively. Further inspection of their DNA sequences revealed that these strains lacked the 137 
PstI enzyme restriction site due to sequence variation at this site, resulting in their 138 
misclassification as stx2d-activatable–positive using the restriction analysis approach only.  139 
Ten of the 11 strains were further tested for the activatibility of the produced Stx by the 140 
mouse intestinal mucus and elastase (Table 2). The Stx of each of the four ovine strains, and 141 
of one of two bovine strains which contained stx2d-activatable was activatable by both the mucus 142 
and elastase as demonstrated by a significant increase in the Vero cell Stx titers of these 143 
strains after preincubation with the respective components; the remaining bovine strain 144 
(3950/1) did not display the activatable phenotype. The other four bovine isolates harboured 145 
the stx2c allele, and, accordingly, did not show any activation in their Vero cell cytotoxicity by 146 
the mucus and elastase (Table 2). 147 
None of the 11 strains investigated was positive for stx1, eae, EHEC-hlyA or saa genes.  148 
Intimin negative, Stx2dactivatable-producing STEC have been associated with sporadic cases and 149 
outbreaks of HC and HUS (Paton et al., 1999; Melton-Celsa et al., 2002; Jelacic et al., 2003). 150 
Recently, Bielaszewska et al. (2006) demonstrated that, while eae-negative STEC strains are, 151 
in general, mostly isolated from individuals with no or only mild disease, those eae-negative 152 
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STEC associated with severe clinical outcomes, such as bloody diarrhea and HUS, mostly 153 
possess stx2d-activatable as the sole stx gene. This indicates a high pathogenic potential of such 154 
strains for humans. 155 
Interestingly, all ovine strains that harboured stx2d-activatable and produced the activatable Stx 156 
belonged to the same serotype O87:H16 (Table 1), though no evident epidemiological 157 
association between these strains could be demonstrated.  Further investigations are ongoing 158 
in our laboratories to determine if these strains have a clonal origin. Among 60 ovine strains, 159 
which were previously characterized (Zweifel et al., 2004), the serotype O87:H16 was one of 160 
the most frequently found (18% of the strains). However, 7 (64%) of these 11 strains 161 
harboured the stx2d allele originally described by Pierard et al. (1998). 162 
The only bovine isolate which produced Stx2dactivatable belonged to serotype ONT:H21. 163 
Notably, this serotype was found to be associated with human disease in a study involving a 164 
large number of human clinical isolates (Bielaszewska et al., 2006). The other frequent 165 
serotypes possessing stx2d-activatable that were isolated from patients, specifically O22:H21, 166 
O91:H21, and O113:H21 (Bielaszewska et al., 2006), were not found in animal feces in our 167 
study, probably due to the limited number of strains analyzed. Presence of such strains in the 168 
intestinal tract of reservoir animals is supported by the fact that these serotypes were also the 169 
most frequent among STEC containing stx2d-activatable  isolated from food (Beutin et al., 2007). 170 
There is presently limited data available regarding the occurrence of strains harbouring the 171 
stx2d-activatable gene in livestock sources. Gobius et al. (2003) examined STEC strains isolated 172 
from food and livestock sources by PCR-RFLP analysis. This study identified activatable stx2d 173 
variants in 12 STEC strains. The strains belonged mainly to the serotypes O174:H8 and 174 
O174:H21, and predominantly originated from bovine sources. Moreover, one O8:H19 strain 175 
harbouring stx2d-activatable originated from lamb meat. However, as demonstrated by our data, 176 
the detection of the stx2d-activatable genotype based solely on the PstI RFLP may be misleading 177 
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because of the possible lack of the restriction site for this enzyme in the stx2c sequence of 178 
some strains. Thus, unless further confirmed by the A subunit sequence analysis, and without 179 
performing the biological assay confirming the activatable phenotype, data on the prevalence 180 
of stx2d-activatable based on PstI restriction analysis approach alone may be confounded by false 181 
identification of strains harbouring stx2c. Bertin et al. (2001) described an stx2 subtype, 182 
designated stx2-NV206, in an O6:H10 STEC isolate from a healthy cow. The stx2-NV206 183 
operon also possesses Ser291 and Glu297, which is typical for the A2 subunit of Stx2dactivatable.  184 
To our knowledge, our study is the first sequence-based evidence reporting the presence of 185 
STEC strains harbouring the stx2d-activatable gene in fecal samples of sheep. Therefore, sheep 186 
seem to be, in addition to cattle (Gobius et al., 2003), a reservoir for non–O157, eae-negative, 187 
stx2d-activatable-harbouring STEC. These STEC carriers represent a source of carcass 188 
contamination as the fecal carriage of food-borne pathogens among livestock animals is 189 
strongly correlated with the hazard of carcasses contamination at slaughter (Bonardi et al., 190 
2001). In order to reduce the risk represented by zoonotic agents to consumer health, it is 191 
essential to reduce contamination of carcasses during the slaughtering processes. Therefore, 192 
the maintenance of slaughter hygiene, which can be measured in daily practice by “in-193 
process-controls” and regular microbiological monitoring of carcasses, is consequently of 194 
central importance in meat production. Moreover, preventive measures, such as 195 
implementation of codes of good manufacturing practices, increased care during hiding and 196 
evisceration as well as improvement of the veterinary meat inspection practices, should be 197 
encouraged. A long-term and consequent application of such measurements is necessary to 198 
reduce the occurrence of STEC harbouring stx2d-activatable in foods and thus there threat as 199 
human pathogens.  200 
 201 
 202 
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Table 1. Characterization of the 11 STEC strains used in this study 288 
 289 
strain origin serotype stx1 stx2 
    restriction fragment 
analysis* 
predicted A2 subunit 
amino acid sequence 
evaluation 
77/1 sheep O87:H16 - stx2d-activatable Stx2dactivatable 
109  sheep O87:H16 - stx2d-activatable Stx2dactivatable 
262/4 sheep O87:H16 - stx2d-activatable Stx2dactivatable 
540  sheep O87:H16 - stx2d-activatable Stx2dactivatable 
3750/1  cattle O2:H29 - stx2d-activatable Stx2c 
3950/1  cattle O148:H8 - stx2d-activatable Stx2dactivatable 
STM1 cattle O174:H21 - stx2c nd 
STM 4/1  cattle ONT:H21 - stx2d-activatable Stx2dactivatable 
MM1 cattle ONT:H- - stx2d-activatable Stx2c 
MM2  cattle ONT:H- - stx2d-activatable Stx2c 
MM3 cattel ONT:H- - stx2d-activatable Stx2c 
*according to Jelacic et al. (2003) 290 
nd, not done 291 
292 
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Table 2. Results of mucus and elastase Stx activatibility assay on Vero cells  292 
 293 
 294 
Strain Vero cell 
titer § 
with 
HEPES3 
Vero cell 
titer with 
mouse 
mucus 
Vero cell 
titer 
increase 
mucus 
x-fold4 
Vero cell 
titer with 
phosphate 
buffer5 
Vero cell 
titer with 
elastase6 
(1 U) 
Vero cell 
titer increase 
elastase 
x-fold4 
stx allele 
determined by 
sequencing 
B2F11  256 2048 8x 256 2048 8x stx2d-activatable 
E325112 512 512 0 512 512 0 stx2c 
77/1 16 128 8x 8 64 8x stx2d-activatable 
109 128 1024 8x 64 256 4x stx2d-activatable 
262/4 16 128 8x 16 64 4x stx2d-activatable 
540 256 1024 4x 256 1024 4x stx2d-activatable 
3750/1 32 32 0 32 64 2x stx2c 
3950/1 64 64 0 64 64 0 stx2d-activatable 
STM 1 n.t. n.t. n.t. n.t. n.t. n.t. n.t. 
STM 4/1 2 8 4x 2 16 8x stx2d-activatable 
MM1 32 32 0 16 32 2x stx2c 
MM2 256 256 0 256 512 2x stx2c 
MM3 16 16 0 32 32 0 stx2c 
§ The highest dilution of the supernatant, which caused cytotoxic effect in 50% of cells after 3 295 
days of incubation 296 
1 stx2d-activatable, positive control 297 
2 stx2c, negativ control 298 
3 diluent for mucus 299 
4The toxin is considered to be activatable when the cytotoxicity titer increased at least 4-fold 300 
after incubation with mucus or 1 unit of the elastase 301 
5 diluent for elastase 302 
6 porcine pancreatic elastase (EC 3.4.21.36; Calbiochem, Darmstadt, Germany) 303 
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